Safety of RIV4 Versus IIV4 in Pregnant Women
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 360
Summary
- Conditions
- Adverse Event Following Immunisation
- Birth Outcomes
- Safety
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03969641
- Collaborators
- Children's Hospital Medical Center, Cincinnati
- Boston Medical Center
- Centers for Disease Control and Prevention
- Investigators
- Principal Investigator: Geeta K Swamy, MD Duke University Principal Investigator: Karen R Broder, MD Centers for Disease Control and Prevention